Survival in multiple myeloma patients who develop second malignancies : a population-based cohort study

Survival in multiple myeloma (MM) has improved significantly during recent decades both in younger and older patients.[1][1],[2][2] The improved survival is considered to be primarily due to new treatment options in MM, including high-dose melphalan with autologous stem cell transplantation,[3][3]